Private Ocean, LLC Ascendis Pharma A/S Transaction History

Private Ocean, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$123.45 - $159.4 $29,751 - $38,415	241 New	241 $36,000
Q3 2022 Oct 21, 2022	BUY	$84.03 - $110.23 $40,418 - $53,020	481 New	481 $49,000
Q2 2022 Jul 25, 2022	SELL	$78.08 - $117.61 $37,556 - $56,570	-481 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$112.67 - $176.92 $54,081 - $84,921	-480 Reduced 49.95%	481 $77,000
Q1 2021 Apr 20, 2021	BUY	$124.92 - $173.33 $120,048 - $166,570	961 New	961 $124,000
Q3 2020 Oct 30, 2020	SELL	$134.29 - $154.32 $129,052 - $148,301	-961 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$62.15 - $129.99 $59,726 - $124,920	961 New	961 $113,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Private Ocean, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Ocean, LLC with notifications on news.